1. Home
  2. UPC vs BENF Comparison

UPC vs BENF Comparison

Compare UPC & BENF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UPC
  • BENF
  • Stock Information
  • Founded
  • UPC 1998
  • BENF 2003
  • Country
  • UPC China
  • BENF United States
  • Employees
  • UPC N/A
  • BENF N/A
  • Industry
  • UPC Biotechnology: Pharmaceutical Preparations
  • BENF Blank Checks
  • Sector
  • UPC Health Care
  • BENF Finance
  • Exchange
  • UPC Nasdaq
  • BENF Nasdaq
  • Market Cap
  • UPC 2.2M
  • BENF 2.6M
  • IPO Year
  • UPC 2021
  • BENF N/A
  • Fundamental
  • Price
  • UPC $3.65
  • BENF $0.30
  • Analyst Decision
  • UPC
  • BENF
  • Analyst Count
  • UPC 0
  • BENF 0
  • Target Price
  • UPC N/A
  • BENF N/A
  • AVG Volume (30 Days)
  • UPC 71.0K
  • BENF 2.6M
  • Earning Date
  • UPC 07-07-2025
  • BENF 08-13-2025
  • Dividend Yield
  • UPC N/A
  • BENF N/A
  • EPS Growth
  • UPC N/A
  • BENF N/A
  • EPS
  • UPC N/A
  • BENF N/A
  • Revenue
  • UPC $23,024,458.00
  • BENF N/A
  • Revenue This Year
  • UPC N/A
  • BENF N/A
  • Revenue Next Year
  • UPC N/A
  • BENF N/A
  • P/E Ratio
  • UPC N/A
  • BENF N/A
  • Revenue Growth
  • UPC N/A
  • BENF N/A
  • 52 Week Low
  • UPC $2.51
  • BENF $0.22
  • 52 Week High
  • UPC $2,592.00
  • BENF $6.27
  • Technical
  • Relative Strength Index (RSI)
  • UPC 41.11
  • BENF 44.42
  • Support Level
  • UPC $3.45
  • BENF $0.26
  • Resistance Level
  • UPC $4.10
  • BENF $0.30
  • Average True Range (ATR)
  • UPC 0.23
  • BENF 0.03
  • MACD
  • UPC -0.03
  • BENF -0.00
  • Stochastic Oscillator
  • UPC 37.78
  • BENF 34.52

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

About BENF Beneficient

Beneficient is a technology-enabled financial services holding company that (together with its subsidiaries) provides simple, rapid, and cost-effective liquidity solutions to participants in the alternative asset industry through its end-to-end online platform, AltAccess. BCG's products and services are designed to meet the unmet needs of mid-to-high net-worth individual investors, small-to-midsize institutional investors, family offices, and fund general partners. Its bespoke liquidity solutions for otherwise illiquid alternative asset investments are delivered through proprietary technology and an innovative financing and trust structure. It has three reportable segments consisting of Ben Liquidity, Ben Custody and Customer ExAlt Trusts.

Share on Social Networks: